Nifty

:

15885.15

Sensex

:

52950.63

122.10 (0.77%)
363.79 (0.69%)

Login

Nifty
Sensex

:
:

15885.15
52950.63

122.10 (0.77%)
363.79 (0.69%)

Hikal Ltd.

Pharmaceuticals & Drugs - Global

Rating :

60/99

BSE: 524735 | NSE: HIKAL

Watchlist

NSE BSE

549.65

02-Aug-2021

Open
High
Low
Previous Close

535.00
565.00
533.00
535.10

Volume
Traded Value (lacs)
52 Week High
52 Week Low

491046
2717.82
572.70
130.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

6,760.58
50.77
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

7,341.73
0.36%
7.24

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

11.61
10.24
5.16

EBITDA CAGR (%)

10 Years
5 Years
3 Years

8.63
8.60
2.47

PAT CAGR (%)

10 Years
5 Years
3 Years

8.60
15.43
3.02

P:E (Median)

8 Years
5 Years
3 Years

26.04
25.67
21.95

P:BV (Average)

8 Years
5 Years
3 Years

2.84
3.04
2.71

EV:EBITDA (Average)

8 Years
5 Years
3 Years

9.51
10.50
9.84

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 21 Mar 20 Var% Dec 20 Dec 19 Var% Sep 20 Sep 19 Var% Jun 20 Jun 19 Var%
Net Sales 532.46 378.99 40.49% 463.29 404.06 14.66% 371.92 321.05 15.84% 352.77 403.16 -12.50%
Expenses 423.20 308.36 37.24% 371.97 328.41 13.26% 302.15 262.69 15.02% 300.29 334.65 -10.27%
EBITDA 109.26 70.63 54.69% 91.32 75.65 20.71% 69.77 58.36 19.55% 52.48 68.51 -23.40%
EBIDTM 20.52% 18.64% 19.71% 18.72% 18.76% 18.18% 14.88% 16.99%
Other Income 2.87 1.73 65.90% 0.52 0.47 10.64% 0.95 0.82 15.85% 0.64 0.68 -5.88%
Interest 9.97 13.70 -27.23% 8.05 13.09 -38.50% 8.50 13.58 -37.41% 9.62 12.05 -20.17%
Depreciation 21.55 20.94 2.91% 21.81 20.69 5.41% 21.17 20.51 3.22% 20.71 20.32 1.92%
PBT 80.61 37.72 113.71% 61.98 42.34 46.39% 41.05 9.69 323.63% 22.79 36.82 -38.10%
Tax 29.69 13.25 124.08% 21.70 13.98 55.22% 14.10 3.32 324.70% 7.79 11.59 -32.79%
PAT 50.92 24.47 108.09% 40.28 28.36 42.03% 26.95 6.37 323.08% 15.00 25.23 -40.55%
PATM 9.56% 6.46% 8.69% 7.02% 7.25% 1.98% 4.25% 6.26%
EPS 4.13 1.98 108.59% 3.27 2.30 42.17% 2.19 0.52 321.15% 1.22 2.05 -40.49%

Description Mar 21 Mar 20 Var% Dec 20 Dec 19 Var% Sep 20 Sep 19 Var% Jun 20 Jun 19 Var%
Net Sales 532.46 378.99 40.49% 463.29 404.06 14.66% 371.92 321.05 15.84% 352.77 403.16 -12.50%
Expenses 423.20 308.36 37.24% 371.97 328.41 13.26% 302.15 262.69 15.02% 300.29 334.65 -10.27%
EBITDA 109.26 70.63 54.69% 91.32 75.65 20.71% 69.77 58.36 19.55% 52.48 68.51 -23.40%
EBIDTM 20.52% 18.64% 19.71% 18.72% 18.76% 18.18% 14.88% 16.99%
Other Income 2.87 1.73 65.90% 0.52 0.47 10.64% 0.95 0.82 15.85% 0.64 0.68 -5.88%
Interest 9.97 13.70 -27.23% 8.05 13.09 -38.50% 8.50 13.58 -37.41% 9.62 12.05 -20.17%
Depreciation 21.55 20.94 2.91% 21.81 20.69 5.41% 21.17 20.51 3.22% 20.71 20.32 1.92%
PBT 80.61 37.72 113.71% 61.98 42.34 46.39% 41.05 9.69 323.63% 22.79 36.82 -38.10%
Tax 29.69 13.25 124.08% 21.70 13.98 55.22% 14.10 3.32 324.70% 7.79 11.59 -32.79%
PAT 50.92 24.47 108.09% 40.28 28.36 42.03% 26.95 6.37 323.08% 15.00 25.23 -40.55%
PATM 9.56% 6.46% 8.69% 7.02% 7.25% 1.98% 4.25% 6.26%
EPS 4.13 1.98 108.59% 3.27 2.30 42.17% 2.19 0.52 321.15% 1.22 2.05 -40.49%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 1,720.44 1,507.26 1,589.61 1,296.09 1,013.94 925.65 871.85 829.21 660.42 694.24 493.51 Net Sales Growth 14.14% -5.18% 22.65% 27.83% 9.54% 6.17% 5.14% 25.56% -4.87% 40.67% Cost Of Goods Sold 908.38 776.32 853.82 698.90 508.88 464.89 427.14 376.04 261.31 310.81 211.39 Gross Profit 812.06 730.94 735.79 597.19 505.06 460.76 444.71 453.17 399.11 383.43 282.13 GP Margin 47.20% 48.49% 46.29% 46.08% 49.81% 49.78% 51.01% 54.65% 60.43% 55.23% 57.17% Total Expenditure 1,397.61 1,234.10 1,291.48 1,054.35 816.74 744.72 689.35 641.93 476.02 510.82 371.21 Power & Fuel Cost - 129.99 132.04 108.41 85.63 83.70 93.85 97.09 88.80 73.35 54.22 % Of Sales - 8.62% 8.31% 8.36% 8.45% 9.04% 10.76% 11.71% 13.45% 10.57% 10.99% Employee Cost - 156.57 135.69 128.06 116.69 108.06 89.20 79.02 70.18 55.69 52.70 % Of Sales - 10.39% 8.54% 9.88% 11.51% 11.67% 10.23% 9.53% 10.63% 8.02% 10.68% Manufacturing Exp. - 85.78 83.61 50.48 38.41 32.69 26.98 23.25 19.29 21.18 16.14 % Of Sales - 5.69% 5.26% 3.89% 3.79% 3.53% 3.09% 2.80% 2.92% 3.05% 3.27% General & Admin Exp. - 43.05 35.77 28.33 30.77 26.77 24.84 23.08 19.63 18.30 14.44 % Of Sales - 2.86% 2.25% 2.19% 3.03% 2.89% 2.85% 2.78% 2.97% 2.64% 2.93% Selling & Distn. Exp. - 20.45 23.36 22.52 18.02 17.09 18.92 16.02 10.97 16.00 13.65 % Of Sales - 1.36% 1.47% 1.74% 1.78% 1.85% 2.17% 1.93% 1.66% 2.30% 2.77% Miscellaneous Exp. - 21.95 27.19 17.66 18.34 11.53 8.42 27.45 5.86 15.49 13.65 % Of Sales - 1.46% 1.71% 1.36% 1.81% 1.25% 0.97% 3.31% 0.89% 2.23% 1.76% EBITDA 322.83 273.16 298.13 241.74 197.20 180.93 182.50 187.28 184.40 183.42 122.30 EBITDA Margin 18.76% 18.12% 18.75% 18.65% 19.45% 19.55% 20.93% 22.59% 27.92% 26.42% 24.78% Other Income 4.98 3.70 2.26 4.46 3.44 1.84 1.58 34.05 6.31 4.96 5.96 Interest 36.14 52.42 58.43 49.12 48.27 62.19 60.05 68.00 59.88 64.03 41.24 Depreciation 85.24 82.46 92.88 85.59 69.14 67.28 64.18 55.02 49.06 42.42 38.19 PBT 206.43 141.98 149.09 111.49 83.22 53.31 59.86 98.31 81.76 81.92 48.84 Tax 73.28 42.14 46.01 34.27 12.55 11.99 19.35 34.23 7.82 5.99 1.39 Tax Rate 35.50% 33.29% 30.86% 30.74% 15.08% 22.49% 32.33% 34.82% 23.46% 9.97% 3.04% PAT 133.15 84.44 103.08 77.23 70.67 41.32 40.51 64.08 25.50 54.08 44.29 PAT before Minority Interest 133.15 84.44 103.08 77.23 70.67 41.32 40.51 64.08 25.50 54.08 44.29 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 7.74% 5.60% 6.48% 5.96% 6.97% 4.46% 4.65% 7.73% 3.86% 7.79% 8.97% PAT Growth 57.70% -18.08% 33.47% 9.28% 71.03% 2.00% -36.78% 151.29% -52.85% 22.10% EPS 10.80 6.85 8.36 6.26 5.73 3.35 3.29 5.20 2.07 4.39 3.59

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 1,720.44 1,507.26 1,589.61 1,296.09 1,013.94 925.65 871.85 829.21 660.42 707.81 502.30 Net Sales Growth 14.14% -5.18% 22.65% 27.83% 9.54% 6.17% 5.14% 25.56% -6.70% 40.91% Cost Of Goods Sold 908.38 776.32 853.82 698.90 508.88 464.89 427.14 376.04 261.31 312.98 212.77 Gross Profit 812.06 730.94 735.79 597.19 505.06 460.76 444.71 453.17 399.11 394.83 289.52 GP Margin 47.20% 48.49% 46.29% 46.08% 49.81% 49.78% 51.01% 54.65% 60.43% 55.78% 57.64% Total Expenditure 1,397.61 1,234.11 1,291.48 1,054.35 815.48 744.81 689.44 642.09 476.25 524.57 382.97 Power & Fuel Cost - 129.99 132.04 108.41 85.63 83.70 93.85 97.09 88.80 73.70 55.10 % Of Sales - 8.62% 8.31% 8.36% 8.45% 9.04% 10.76% 11.71% 13.45% 10.41% 10.97% Employee Cost - 156.57 135.69 128.06 116.69 108.06 89.20 79.02 70.18 63.66 58.88 % Of Sales - 10.39% 8.54% 9.88% 11.51% 11.67% 10.23% 9.53% 10.63% 8.99% 11.72% Manufacturing Exp. - 85.78 83.61 50.48 38.41 32.69 26.98 23.25 19.29 22.24 17.22 % Of Sales - 5.69% 5.26% 3.89% 3.79% 3.53% 3.09% 2.80% 2.92% 3.14% 3.43% General & Admin Exp. - 43.05 35.77 28.33 30.77 26.86 24.93 23.24 19.86 19.43 15.88 % Of Sales - 2.86% 2.25% 2.19% 3.03% 2.90% 2.86% 2.80% 3.01% 2.75% 3.16% Selling & Distn. Exp. - 20.45 23.36 22.52 18.02 17.09 18.92 16.02 10.97 16.24 13.82 % Of Sales - 1.36% 1.47% 1.74% 1.78% 1.85% 2.17% 1.93% 1.66% 2.29% 2.75% Miscellaneous Exp. - 21.95 27.19 17.66 17.09 11.53 8.42 27.45 5.86 16.33 13.82 % Of Sales - 1.46% 1.71% 1.36% 1.69% 1.25% 0.97% 3.31% 0.89% 2.31% 1.85% EBITDA 322.83 273.15 298.13 241.74 198.46 180.84 182.41 187.12 184.17 183.24 119.33 EBITDA Margin 18.76% 18.12% 18.75% 18.65% 19.57% 19.54% 20.92% 22.57% 27.89% 25.89% 23.76% Other Income 4.98 3.70 2.26 4.46 3.44 1.84 1.58 34.05 6.31 1.40 3.30 Interest 36.14 52.42 58.43 49.12 48.27 62.21 60.05 68.01 59.89 66.38 43.72 Depreciation 85.24 82.46 92.88 85.59 69.14 67.28 64.19 55.04 49.07 45.31 41.03 PBT 206.43 141.98 149.08 111.49 84.47 53.19 59.75 98.13 81.50 72.96 37.87 Tax 73.28 42.14 46.01 34.27 12.55 11.99 19.35 34.23 7.82 5.07 -2.31 Tax Rate 35.50% 33.29% 30.86% 30.74% 15.64% 22.54% 32.38% 34.88% 23.65% 9.92% -6.65% PAT 133.15 84.44 103.08 77.23 67.72 41.20 40.41 63.90 25.25 46.03 37.02 PAT before Minority Interest 133.15 84.44 103.08 77.23 67.72 41.20 40.41 63.90 25.25 46.03 37.02 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 7.74% 5.60% 6.48% 5.96% 6.68% 4.45% 4.63% 7.71% 3.82% 6.50% 7.37% PAT Growth 57.70% -18.08% 33.47% 14.04% 64.37% 1.95% -36.76% 153.07% -45.14% 24.34% EPS 10.80 6.85 8.36 6.26 5.49 3.34 3.28 5.18 2.05 3.73 3.00

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 816.52 756.22 669.39 604.99 564.90 533.47 505.90 451.25 459.82 421.68 Share Capital 24.66 24.66 16.44 16.44 16.44 16.44 16.44 16.44 16.44 16.44 Total Reserves 791.86 731.56 652.96 588.55 548.46 517.03 489.46 434.81 443.38 405.24 Non-Current Liabilities 410.16 359.42 311.82 324.23 336.88 241.67 298.23 237.91 241.97 241.55 Secured Loans 303.40 297.84 296.63 320.15 296.61 201.44 254.56 213.43 221.38 231.88 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.27 6.20 5.50 0.70 Long Term Provisions 73.43 48.74 15.65 14.30 10.22 11.71 10.92 9.66 6.42 6.28 Current Liabilities 652.77 659.02 616.17 470.29 397.31 529.99 466.61 502.80 438.61 391.24 Trade Payables 201.16 160.00 164.55 130.43 127.85 137.13 131.09 112.84 113.93 81.99 Other Current Liabilities 133.28 136.11 113.94 75.93 62.03 131.52 100.19 123.63 106.25 104.78 Short Term Borrowings 257.54 301.88 277.16 230.24 171.94 231.01 215.55 260.28 205.47 191.34 Short Term Provisions 60.80 61.03 60.52 33.69 35.49 30.33 19.79 6.04 12.97 13.13 Total Liabilities 1,879.45 1,774.66 1,597.38 1,399.51 1,299.09 1,305.13 1,270.74 1,191.96 1,140.40 1,054.47 Net Block 735.22 712.96 633.59 668.33 623.18 639.35 644.14 660.76 578.40 575.53 Gross Block 1,064.92 960.28 788.33 737.47 1,147.15 1,096.04 1,032.04 993.22 852.13 806.12 Accumulated Depreciation 329.70 247.31 154.73 69.14 523.97 456.69 387.90 332.46 273.74 230.59 Non Current Assets 1,048.23 888.18 851.30 792.72 808.90 792.08 776.15 782.84 794.92 746.13 Capital Work in Progress 160.82 78.69 117.88 62.76 66.13 61.66 61.17 48.54 74.76 51.21 Non Current Investment 0.69 1.03 2.61 3.63 3.13 3.13 3.13 3.13 18.17 18.17 Long Term Loans & Adv. 145.30 85.40 91.55 37.81 86.61 72.94 67.72 70.42 123.60 101.22 Other Non Current Assets 6.21 10.11 5.67 20.20 29.86 15.00 0.00 0.00 0.00 0.00 Current Assets 831.22 886.48 746.08 606.79 490.19 513.04 494.60 409.12 345.47 308.34 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 312.46 364.23 303.05 263.58 291.11 313.95 311.29 257.03 191.85 171.51 Sundry Debtors 340.44 349.72 287.37 256.47 112.31 127.97 88.74 84.63 98.73 85.22 Cash & Bank 63.57 31.74 27.22 16.46 19.16 13.69 27.69 15.40 5.92 8.80 Other Current Assets 114.74 8.42 14.50 10.73 67.62 57.43 66.88 52.05 48.97 42.80 Short Term Loans & Adv. 104.25 132.37 113.93 59.54 57.43 35.02 33.52 27.59 29.47 26.49 Net Current Assets 178.45 227.46 129.91 136.51 92.88 -16.94 27.98 -93.68 -93.13 -82.90 Total Assets 1,879.45 1,774.66 1,597.38 1,399.51 1,299.09 1,305.12 1,270.75 1,191.96 1,140.39 1,054.47

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 816.50 756.21 669.38 604.98 563.78 532.48 504.71 450.27 430.60 400.49 Share Capital 24.66 24.66 16.44 16.44 16.44 16.44 16.44 16.44 16.44 16.44 Total Reserves 791.84 731.55 652.95 588.54 547.34 516.04 488.27 433.83 414.16 384.05 Non-Current Liabilities 410.16 359.42 311.82 324.23 336.88 241.67 298.23 237.91 253.50 259.71 Secured Loans 303.40 297.84 296.63 320.15 296.61 201.44 254.56 213.43 240.18 256.58 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.27 6.20 5.50 0.70 Long Term Provisions 73.43 48.74 15.65 14.30 10.22 11.71 10.92 9.66 7.01 6.71 Current Liabilities 652.77 659.02 616.17 470.29 397.36 530.07 478.92 502.90 447.63 400.35 Trade Payables 201.16 160.01 164.55 130.43 127.87 137.21 131.19 112.94 114.47 83.12 Other Current Liabilities 133.28 136.11 113.94 75.93 62.03 131.52 100.19 123.63 114.56 112.65 Short Term Borrowings 257.54 301.88 277.16 230.24 171.96 231.01 215.55 260.28 205.47 191.34 Short Term Provisions 60.80 61.03 60.52 33.69 35.49 30.33 31.99 6.04 13.12 13.24 Total Liabilities 1,879.43 1,774.65 1,597.37 1,399.50 1,298.02 1,304.22 1,281.86 1,191.08 1,131.73 1,060.55 Net Block 735.22 712.96 633.59 668.33 623.18 639.35 643.85 660.48 639.30 635.29 Gross Block 1,064.92 960.28 788.33 737.47 1,147.23 1,096.12 1,031.78 992.97 922.32 872.28 Accumulated Depreciation 329.70 247.31 154.73 69.14 524.05 456.77 387.93 332.49 283.02 236.99 Non Current Assets 1,048.22 888.17 851.29 792.71 807.83 791.16 775.07 781.92 773.46 736.15 Capital Work in Progress 160.82 78.69 117.88 62.76 66.13 61.66 61.17 48.54 75.57 51.21 Non Current Investment 0.68 1.02 2.60 3.62 3.12 3.12 3.12 3.12 3.12 3.12 Long Term Loans & Adv. 145.30 85.40 91.55 37.81 85.55 72.03 66.93 69.78 55.47 46.53 Other Non Current Assets 6.21 10.11 5.67 20.20 29.86 15.00 0.00 0.00 0.00 0.00 Current Assets 831.22 886.48 746.08 606.79 490.19 513.06 506.79 409.17 358.26 324.40 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 312.46 364.23 303.05 263.58 291.11 313.95 311.29 257.03 192.77 172.28 Sundry Debtors 340.44 349.72 287.37 256.47 112.31 127.97 88.74 84.63 101.97 88.03 Cash & Bank 63.57 31.74 27.22 16.46 19.16 13.70 27.68 15.44 6.88 10.09 Other Current Assets 114.74 8.42 14.50 10.73 67.62 57.43 79.08 52.06 56.64 54.01 Short Term Loans & Adv. 104.25 132.37 113.93 59.54 57.43 35.02 45.72 27.60 36.05 36.34 Net Current Assets 178.44 227.45 129.91 136.51 92.84 -17.02 27.87 -93.73 -89.36 -75.95 Total Assets 1,879.44 1,774.65 1,597.37 1,399.50 1,298.02 1,304.22 1,281.86 1,191.09 1,131.72 1,060.55

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 284.93 185.59 138.81 163.49 185.70 102.27 154.59 61.32 136.68 113.24 PBT 141.98 149.09 111.49 83.22 53.31 59.86 98.31 33.33 60.07 45.68 Adjustment 136.17 158.81 140.35 123.92 133.60 126.79 112.36 105.66 86.39 65.12 Changes in Working Capital 46.49 -89.69 -87.16 -23.92 11.41 -71.31 -35.96 -72.28 -1.09 11.44 Cash after chg. in Working capital 324.64 218.21 164.69 183.22 198.31 115.34 174.70 66.71 145.36 122.24 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -24.31 -32.62 -25.87 -19.73 -12.61 -13.06 -20.11 -5.39 -8.69 -9.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items -15.40 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -163.80 -124.59 -110.12 -102.59 -64.07 -43.00 -23.01 -28.21 -62.22 -71.09 Net Fixed Assets -186.77 -132.76 -105.98 413.05 -55.58 -64.49 -51.45 -114.87 -69.56 -67.97 Net Investments 0.34 1.58 1.02 -0.50 0.00 0.00 0.00 15.04 0.00 0.00 Others 22.63 6.59 -5.16 -515.14 -8.49 21.49 28.44 71.62 7.34 -3.12 Cash from Financing Activity -100.86 -55.41 -24.79 -63.27 -123.56 -68.82 -124.42 -26.79 -78.31 -47.26 Net Cash Inflow / Outflow 20.27 5.59 3.90 -2.37 -1.92 -9.54 7.16 6.31 -3.85 -5.11 Opening Cash & Equivalents 11.41 5.82 1.93 4.29 6.21 15.76 8.60 1.99 5.84 10.95 Closing Cash & Equivalent 31.68 11.41 5.82 1.93 4.29 6.21 15.76 8.60 1.99 5.84

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 284.93 185.59 138.81 163.48 185.61 102.18 154.41 61.05 136.52 108.01 PBT 141.98 149.08 111.49 80.27 53.19 59.75 98.13 33.07 51.11 34.71 Adjustment 136.17 158.81 140.35 126.88 133.68 126.82 112.36 105.39 95.41 73.19 Changes in Working Capital 46.49 -89.69 -87.16 -23.93 11.35 -71.33 -35.96 -72.02 -1.32 8.74 Cash after chg. in Working capital 324.64 218.21 164.69 183.22 198.22 115.24 174.53 66.44 145.20 116.64 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -24.31 -32.62 -25.87 -19.73 -12.61 -13.06 -20.11 -5.39 -8.68 -8.63 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items -15.40 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -163.80 -124.59 -110.12 -102.17 -63.91 -42.89 -22.86 -28.02 -53.62 -74.64 Net Fixed Assets -186.77 -132.76 -105.98 413.05 -55.58 -64.49 -51.45 -114.87 -69.56 -67.97 Net Investments 0.34 1.58 1.02 -0.50 0.00 0.00 0.00 15.04 0.00 0.00 Others 22.63 6.59 -5.16 -514.72 -8.33 21.60 28.59 71.81 15.94 -6.67 Cash from Financing Activity -100.86 -55.40 -24.79 -63.28 -123.63 -68.82 -124.43 -27.01 -87.09 -38.05 Net Cash Inflow / Outflow 20.27 5.59 3.90 -1.96 -1.93 -9.53 7.12 6.02 -4.19 -4.68 Opening Cash & Equivalents 11.41 5.82 1.93 3.89 6.23 15.75 8.63 2.62 6.81 11.49 Closing Cash & Equivalent 31.68 11.41 5.82 1.93 4.29 6.23 15.75 8.63 2.62 6.81

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 66.22 61.33 54.29 49.07 37.25 34.64 32.34 27.85 28.48 25.33 ROA 4.62% 6.11% 5.15% 5.24% 3.17% 3.15% 5.20% 2.19% 4.93% 4.26% ROE 10.74% 14.46% 12.12% 13.28% 9.32% 9.81% 17.27% 7.34% 16.30% 14.74% ROCE 12.44% 15.25% 12.81% 12.14% 11.92% 12.50% 17.77% 10.44% 14.80% 11.07% Fixed Asset Turnover 1.49 1.82 1.70 1.10 0.83 0.82 0.82 0.72 0.86 0.66 Receivable days 83.56 73.14 76.34 65.09 46.88 45.07 37.91 50.32 47.36 65.61 Inventory Days 81.93 76.61 79.54 97.91 118.04 130.03 124.28 123.17 93.54 126.43 Payable days 52.18 44.26 48.94 56.68 62.71 67.80 66.91 82.40 71.40 81.84 Cash Conversion Cycle 113.32 105.49 106.94 106.32 102.20 107.30 95.28 91.09 69.49 110.20 Total Debt/Equity 0.79 0.87 0.95 0.99 1.10 1.28 1.37 1.70 1.44 1.62 Interest Cover 3.41 3.55 3.27 2.72 1.86 2.00 2.45 1.56 1.94 2.11

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 66.22 61.33 54.29 49.07 37.16 34.56 32.25 27.77 26.11 23.61 ROA 4.62% 6.11% 5.15% 5.02% 3.17% 3.12% 5.17% 2.17% 4.20% 3.51% ROE 10.74% 14.46% 12.12% 12.74% 9.32% 9.81% 17.27% 7.60% 15.02% 13.09% ROCE 12.44% 15.25% 12.81% 11.87% 11.92% 12.50% 17.77% 10.44% 13.97% 9.80% Fixed Asset Turnover 1.49 1.82 1.70 1.10 0.83 0.82 0.82 0.69 0.81 0.62 Receivable days 83.56 73.14 76.34 65.09 46.88 45.07 37.91 51.20 47.99 65.79 Inventory Days 81.93 76.61 79.54 97.91 118.04 130.03 124.28 123.43 92.21 124.67 Payable days 52.18 44.26 48.94 56.69 62.74 67.85 66.97 82.64 69.96 80.79 Cash Conversion Cycle 113.32 105.49 106.94 106.31 102.18 107.25 95.22 91.99 70.24 109.68 Total Debt/Equity 0.79 0.87 0.95 0.99 1.10 1.28 1.37 1.70 1.65 1.84 Interest Cover 3.41 3.55 3.27 2.66 1.85 2.00 2.44 1.55 1.77 1.79

Top Investors:

government pension fund global

si investments and broking private limited

Annual Reports:

News Update:

Hikal reports 2- fold jump in Q4 net profit
6th May 2021, 16:59 PM

Total income of the company increased by 40.61% at Rs 535.33 crore for Q4FY21
Read More
Hikal signs 10-year multi product deal with leading global pharmaceutical innovator company
5th May 2021, 09:45 AM

With this deal, Hikal is entering into a niche area of chemistry and products thereby bolstering its Animal Health vertical
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback